OBiO Technology is a gene and cell therapy CRO and CDMO founded. We offer holistic research, development, and manufacturing solutions for vectorology studies, functional genomics, process and analytical development, IND-enabling CMC, clinical and commercial manufacturing. With "enable gene therapy for better lives" as our mission, we are committed to providing high-quality service to global customers, advancing your product from bench to clinic, and bringing benefit to populations around the world. We are committed to provide high quality CDMO service for preclinical, IND, clinical and commercial stages consumers worldwide.

Plasmids, mRNA
AAV, LVV, Ad viral vector,
Cell therapy manufacturing, CAR-T, NK, Treg...
Oncolytic virus 
Technologies
Inducible viral vector packaging
Ultralow endotoxin process
AAVneO for AAV variants with tissue specific tropism

For business inquiries, please contact bd@obiosh.com. More information and job openings at: www.obio-tech.com.



Biotechnology

Manufacturing

Therapeutics

OBiO Tech

Charles L.

Guodong Javier Jia

Swati Dhage

Weiran Shen

Hung Trinh

Guodong Jia

Shan Yin

Qingmei Xia

Fujie Wang

Bingqing Wang

Qinbin Wu

OBiO Tech

Org chart

Similar companies